INSPIRE MEDICAL SYSTEMS, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 237.4 USD | +2.79% |
|
+3.59% | +16.72% |
| 19/04 | RBC Initiates Inspire Medical Systems at Outperform With $285 Price Target | MT |
| 18/04 | Inspire Medical Systems Insider Sold Shares Worth $3,450,450, According to a Recent SEC Filing | MT |
Chart calendar Inspire Medical Systems, Inc.
e93b6d1b50a59e.LVxleDsw3DQMojwn-t4_HaN-BT4d3-d4LFy0HE8313s.ZTsiOn96vQJ50mZLmIhbcvUSWlVCnqpBQBDlaAxO4jVKBVYRS0rkYD7KcQ~f09e71fca8e8cb797cd03ba711222028
Upcoming events on Inspire Medical Systems, Inc.
Past events on Inspire Medical Systems, Inc.
| 19/03/2024 08:00 pm | KeyBanc Life Sciences & MedTech Forum |
| 07/02/2024 03:30 am | Q4 2023 Earnings Call |
| 07/02/2024 02:32 am | Q4 2023 Earnings Release |
| 08/01/2024 09:00 pm | JPMorgan Healthcare Conference |
| 29/11/2023 12:30 am | Piper Sandler Healthcare Conference |
| 15/11/2023 08:15 pm | Stifel Healthcare Conference |
| 08/11/2023 03:30 am | Q3 2023 Earnings Call |
| 08/11/2023 02:33 am | Q3 2023 Earnings Release |
| 03/10/2023 07:45 pm | American Academy of Otolaryngology Meeting |
| 02/10/2023 04:30 am | American Academy of Otolaryngology Meeting |
| 02/10/2023 02:00 am | American Academy of Otolaryngology Meeting |
| 01/10/2023 11:30 pm | American Academy of Otolaryngology Meeting |
| 01/10/2023 10:30 pm | American Academy of Otolaryngology Meeting |
| 30/09/2023 02:00 am | International Surgical Sleep Society Meeting |
| 06/09/2023 08:30 pm | Wells Fargo Healthcare Conference |
| 02/08/2023 02:30 am | Q2 2023 Earnings Call |
| 02/08/2023 01:32 am | Q2 2023 Earnings Release |
| 22/05/2023 11:30 pm | Wells Fargo Medtech Innovation Spotlight Series |
| 16/05/2023 11:05 pm | RBC Capital Markets Global Healthcare Conference |
| 10/05/2023 10:30 pm | Bank of America Healthcare Conference |
Annual results
| Fiscal Period | December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 82,1 79,0 3.83% | 115 111 3.66% | 233 231 1.2% | 408 408 0.04% | 625 624 0.21% | 782 |
|
EBITDA Million USD | Released Forecast Spread | -28,2 -32,6 13.35% | -42,6 -56,1 24.12% | -38,6 -33,2 -16.44% | 6,24 -11,9 152.32% | 45,0 26,5 70.03% | 66,1 |
|
EBIT Million USD | Released Forecast Spread | -34,9 -35,7 2.21% | -56,2 -61,9 9.18% | -39,9 -49,6 19.74% | -47,6 -64,1 25.7% | -40,3 -54,8 26.47% | -29,2 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -33,2 -34,0 2.32% | -57,1 -63,1 9.46% | -42,0 -51,0 17.73% | -44,3 -65,3 32.24% | -19,9 -36,4 45.34% | -6,87 |
|
Net income Million USD | Released Forecast Spread | -33,2 -33,8 1.69% | -57,2 -62,8 8.89% | -42,0 -51,2 17.81% | -44,9 -64,6 30.49% | -21,2 -37,6 43.73% | -9,05 |
|
EPS USD | Released Forecast Spread | -1,40 -1,42 1.23% | -2,19 -2,40 8.82% | -1,54 -1,87 17.79% | -1,60 -2,30 30.53% | -0,72 -1,28 43.91% | -0,39 |
| Announcement Date | 25/02/20 | 23/02/21 | 08/02/22 | 07/02/23 | 06/02/24 | - |
Quarterly results
| Fiscal Period | December | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 78,4 75,6 3.7% | 69,4 64,2 8.11% | 91,4 78,1 17.07% | 109 94,6 15.41% | 138 138 0.11% | 128 120 6.53% | 151 136 10.7% | 153 155 -0.8% | 193 191 0.67% | 161 | 188 | 197 | 235 | 203 |
|
EBITDA Million USD | Released Forecast Spread | -1,48 -5,00 70.46% | -15,7 -19,0 17.58% | -0,93 -8,46 89% | -2,09 -11,9 82.44% | 15,2 -6,10 349.67% | -0,68 -8,22 91.72% | 5,63 2,57 118.74% | 1,90 2,79 -32.08% | 33,0 15,8 109.09% | -1,42 | 12,4 | 18,7 | 40,5 | 1,84 |
|
EBIT Million USD | Released Forecast Spread | -1,82 -11,6 84.33% | -16,1 -21,7 25.87% | -14,0 -16,6 15.4% | -17,2 -20,8 17.48% | -0,34 -16,7 98% | -19,5 -22,4 13.04% | -16,6 -19,9 16.78% | -13,5 -21,5 37.49% | 9,30 -5,26 276.8% | -25,8 | -12,3 | -7,17 | 15,9 | -13,9 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -2,37 -11,3 79.02% | -16,6 -20,4 18.64% | -14,3 -16,5 12.79% | -16,6 -20,1 17.38% | 3,28 -18,1 118.06% | -15,2 -19,6 22.55% | -11,7 -17,1 31.21% | -8,20 -16,9 51.43% | 15,2 -1,20 1370.2% | -20,0 | -6,91 | -0,97 | 20,9 | -7,97 |
|
Net income Million USD | Released Forecast Spread | -2,39 -11,3 78.83% | -16,7 -20,6 18.91% | -14,5 -16,7 13.09% | -16,8 -20,7 18.57% | 3,15 -16,8 118.74% | -15,4 -19,8 22.05% | -12,0 -16,9 29.43% | -8,54 -16,4 48.01% | 14,8 -1,68 981.37% | -19,7 | -6,77 | -1,15 | 18,5 | -7,54 |
|
EPS USD | Released Forecast Spread | -0,09 -0,42 78.46% | -0,61 -0,75 18.86% | -0,53 -0,60 11.46% | -0,60 -0,76 20.81% | 0,10 -0,58 117.29% | -0,53 -0,65 18.24% | -0,41 -0,58 29.51% | -0,29 -0,56 48.2% | 0,49 -0,06 949.66% | -0,67 | -0,23 | -0,06 | 0,58 | -0,25 |
| Announcement Date | 08/02/22 | 03/05/22 | 02/08/22 | 01/11/22 | 07/02/23 | 02/05/23 | 01/08/23 | 07/11/23 | 06/02/24 | - | - | - | - | - |
| 29/04/2024 | YANTAI ZHENGHAI BIOTECHNOLOGY CO., LTD.: Q1 2024 Earnings Release |
| 29/04/2024 | BEIJING CHUNLIZHENGDA MEDICAL INSTRUMENTS CO., LTD.: Q1 2024 Earnings Release |
| 30/04/2024 | DOUBLE MEDICAL TECHNOLOGY INC.: Q1 2024 Earnings Release |
| 01/05/2024 01:35 am | STRYKER CORPORATION: Q1 2024 Earnings Release |
| 01/05/2024 | JAPAN LIFELINE CO., LTD.: Q4 2023 Earnings Release |
| 01/05/2024 11:30 am | SMITH & NEPHEW PLC: Q1 2024 Sales and Revenue Release - Trading Update |
| 02/05/2024 01:35 am | GLAUKOS CORPORATION: Q1 2024 Earnings Release |
| 02/05/2024 | AXONICS, INC.: Q1 2024 Earnings Release (Projected) |
| 02/05/2024 03:30 pm | ENOVIS CORPORATION: Q1 2024 Earnings Release |
| 06/05/2024 | ORTHOPEDIATRICS CORP.: Q1 2024 Earnings Release |
Past sector events for Inspire Medical Systems, Inc.
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- INSP Stock
- Calendar Inspire Medical Systems, Inc.
